Anti-ulcer activity of curcumin on experimental gastric ulcer in rats and its effect on oxidative Stress/Antioxidant, IL-6 and enzyme activities

Biomedical and Environmental Sciences

Volumn 22, Issue 6, 2009, Pages 488-495

  Tuorkey, M ^a   Karolin, K ^b  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b Alexandria University Faculty Of Science   (Egypt)

Author keywords

Curcumin; Mitochondrial activity and myeloperoxiase activity; Paraoxonase arylesterase activity

Indexed keywords

ANIMALIA; RATTUS;

EID: 77649137229     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-3988(10)60006-2     Document Type: Article

References (26)

1. Wallace J L (2005). Recent advances in gastric ulcer therapeutics. Curr Opin Pharmacol 5, 573-577.
2. Huang A C, Lin S Y, Su C C, et al. (2008). Effects of curcumin on N-bis(2-hydroxypropyl) nitrosamine (DHPN)-induced lung and liver tumorigenesis in BALB/c mice in vivo. In Vivo 22, 781-785.
3. Kurup V P, Barrios C S, Raju R, J et al. (2007). Immune response modulation by curcumin in a latex allergy model. Clin MoI Allergy 5, 1.
4. Varalakshmi C, Ali A M, Pardhasaradhi B V, et al. (2008). Immunomodulatory effects of curcumin: in-vivo. Int lmmunopharmacol 8, 688-700.
5. Churchill M, Chadburn A, Bilinski R T, et al. (2000). Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J Surg Res 89, 169-175.
6. Glienke W, Maute L, Wicht J et al. (2009). Wilms tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells. Eur J Cancer 45, 874-880.
7. Swamy M V, Citineni B, Patlolla J M, et al. (2008). Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids. Nutr Cancer 60, 81-89.
8. Milacic V, Banerjee S, Landis-Piwowar K R, et al. (2008). Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Cancer Res 68, 7283-7292.
9. Jiao Y, Wilkinson J, Di X, Wang W, et al. (2009). Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood 113, 462-469
10. O.Kim Y S, Ahn Y, Hong M H, J et al. (2007). Curcumin attenuates inflammatory responses of TNF-alpha-stimulated human endothelial cells. J Cardiovasc Pharmacol 50, 41-49. (Pubitemid 47220445)
11. 11.Wang Q, Sun A Y, Simonyi A, et al. (2005) Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J Neurosci Res 82, 138-148. (Pubitemid 41604805)
12. HaIf E, Arber N (2009). Colon cancer: preventive agents and the present status of chemoprevention. Expert Opin Pharmacother 10, 211-219.
13. Kettle A J, Winterbourn C C (1994). Assays for the chlorination activity of myeloperoxidase. Methods Enzymol 233, 502-512
14. 14. Aviram M, Rosenblat M, Bisgaier C L, et al. (1998). Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101, 1581-1590. (Pubitemid 28198486)
15. Erel O (2004). A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37, 112-119.
16. 16.Hu M L (1994). Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 233, 380-385. (Pubitemid 24177564)
17. Lowry O H, Roseprough N I, Farr A L, et al. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275.
18. 18.Harma M, Harma M, Erel O (2005). Measurement of the total antioxidant response in preeclampsia with a novel automated method. Eur J Obstet Gynecol Reprod Biol 118, 47-51. (Pubitemid 39647022)
19. 19.Kurita-Ochiai T, Fukushima K, Ochiai K. (1999). Lipopolysaccharide stimulates butyric acid-induced apoptosis in human peripheral blood mononuclear cells. Infect Immun 67, 22-29. (Pubitemid 29021624)
20. Mishra S, Tripathi R D, Srivastava S, et al. (2009). Thiol metabolism play significant role during cadmium detoxification by Ceratophyllum demersum L. Bioresour Technol 100, 2155-2161.
21. 21.Capeillere-Blandin C, Gausson V, Nguyen A T, et al. (2006). Respective role of uraemic toxins and myeloperoxidase in the uraemic state. Nephrol Dial Transplant 21, 1555-1563. (Pubitemid 43840618)
22. Aviram M, Rosenblat M (2008). Paraoxonases (PON1, PON2, PON3) analyses in vitro and in vivo in relation to cardiovascular diseases. Methods MoI Biol 477, 259-276.
23. Tuorkey M J, bdul-Aziz K K (2009). A pioneer study on the anti-ulcer activities of copper nicotinate complex [CuCl (HNA)2] in experimental gastric ulcer induced by aspirin-pylorus ligation model (Shay model). Biomed Pharmacother 63, 194-201.
24. Crabtree J E, Shallcross T M, Heatley R V, et al. (1991). Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32, 1473-1477.
25. 25.Lehmann F S, Stalder G A (1998). Hypotheses on the role of cytokines in peptic ulcer disease. Eur J Clin Invest 28, 511-519. (Pubitemid 28350014)
26. 26.Sathyanarayan G, Garg P K, Prasad H, et al. (2007). Elevated level of interleukin-6 predicts organ failure and severe disease in patients with acute pancreatitis. J Gastroenterol Hepatol 22, 550-554. (Pubitemid 46434982)